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ABSTRACT
Aim and Objectives: The aim of the work is focused on the optimization of the high-performance liquid chromatography (HPLC) method for the 
determination of ninhydrin-positive substances in amino acids using HPLC technique in a single method. Since, most of the amino acids are widely 
used in the determination of Renal and Nutrition drug products exist independently in the monograph for each amino acid either by TLC or HPLC.
Methods: The chromatographic separation was performed using sodium amino acid analysis cation exchange column using Sodium Eluent Na 315, 
Sodium eluent Na 425, and Sodium Eluent Na 640 as Mobile phase, performed by gradient program with detection of wavelength 570 nm using flow 
rate as 0.4 mL/min. The method has been evaluated using post-column derivatization technique (HPLC/Pinnacle PCX).
Results: All the amino acids were eluted correspondingly at the individual retention time and the method shall be validated as per the ICH Q2R1 Guideline.
Conclusion: The method has been successfully evaluated and developed for the analytical applications.
Keywords: Amino acids, Method development, HPLC, RRT, Specificity
INTRODUCTION
Renal and nutrition products mainly contain amino acids. As part of 
the European Pharmacopoeia (EP) testing for these substances, the 
presence of ninhydrin-positive substances (NPS) is determined. This 
determination is performed using either thin-layer chromatography 
(TLC) or high-performance liquid chromatography (HPLC) with post-
column derivatization technique. The monographs are being revised to 
remove TLC method and replace with HPLC method. Since, most of the 
amino acids are being revised to include this HPLC method, amino acids 
such as Taurine and Ornithine Hydrochloride (HCl) whose monograph 
has not been published and not available. This approach assures that 
the method has been developed for all the amino acid substances which 
are used to formulate nutrition and renal products. The EP reporting 
threshold limits for the NPS HPLC method are 0.05% and for ammonium 
are 0.02%.
The aim of the work is focused on the optimization of the HPLC method 
for the NPS in amino acids using HPLC technique [1].
The following amino acids are developed with a single HPLC method 
equipped with post-column derivatizer as follows:
Glycine, L-alanaine, L-arginine, L-aspartic acid, glutamic acid, 
L-histidine, L-isoleucine, L-leucine, L-lysine acetate, L-lysine HCL, 
L-phenyl alanine, L-proline, L-serine, L-threonine, L-tryptophan, 
L-tyrosine, L-valine, taurine, and ornithine HCL [2-21].
Ammonium concentration
Molecular weight of ammonium chloride: 53.491 g/mol
Molecular weight of ammonium: 18.038 g/mol






All the amino acids used for this study were purchased from Sigma-Aldrich, 
and the catalog numbers are mentioned with each amino acid: Glycine-50046, 
L-alanine-05129, L-arginine-11009, L-aspartic acid-11189, L-glutamic 
acid-49449, L-histidine-53319, L-isoleucine-4160, L-leucine-4330, 
L-lysine HCL -L7286, L-phenyl alanine-78019, L-proline-81709, 
L-serine-4959, L-threonine-89179, L-tryptophan-93659, L-tyrosine-93829, 
L-valine-V0500, ornithine HCL -O8305, and taurine-T0625 [2-21].
Reagents and chemicals
Ammonium chloride with catalog number: 09724 and HCL acid with 
catalog number: 84436, both the chemical have been purchased from 
Sigma Aldrich with EP grade.
Instrument and analytical conditions
Mobile phase
Channel A: Sodium eluent Na 315, catalog no. Na 315; Channel B: 
Sodium eluent Na 425, catalog no. Na 425; Channel C: Sodium eluent Na 
640, catalog no. Na 640; Channel D: Sodium regenerant RG011, catalog 
No. RG011; and the entire mobile phase (ready to use solution) have 
been purchased from Pickering Laboratories.
*Channel D: Eluent was used for column flushing, regeneration, and 
storage only.
Derivatizing solution
The Post Column Derivatizing solution used for this method is “TRIONE” 
Ninhydrin reagent, Make: Pickering Laboratories, catalog No. T200[22].
Column
The Analytical Column used for this method is Sodium Amino Acid 
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Analysis Cation Exchange Column, Make: Pickering laboratories, 
Dimension: 110 x 4.3m, 5 µ, Catalog no. 1154110T.
Gradient Table for HPLC, Pinnacle PCX post column derivatization method 
and column temperature gradient program are shown in Tables 1-3.
HPLC method
The Instrument parameters used for HPLC, HPLC make / model and 
software used for this method development were mentioned below:
Flow rate: 0.4 mL/min, injection volume: 50 µL, Run time (min): 
135 min, next injection delay: 1 min, detector wave length: 570 nm [22].
HPLC: Make – Waters HPLC, module: e2695 series with PDA detector 
using pinnacle PCX post column Derivatizer [22].
Software used: Empower-3.
Diluents: Milli Q water, Make: Millipore or Dilute HCL-R1
Preparation of Dilute HCL-R1
Diluted 20 g of HCL into a 100 L with water and further diluted 10.0 mL 
of this solution to 2000mL with water.
Preparation of ammonium 100 ppm standard
Diluted 0.741050 g of ammonium chloride to 1000 mL with water. 
Further, diluted 10 mL of this stock solution to 25 mL with water.
Preparation of reference (c) stock solution (solution A: Water)
Diluted 6 mL of 100 ppm ammonium solution to 50 mL with water.
Preparation of reference (c) stock solution (Solution A: Diluted 
HCL R1)
Diluted 6 mL of 100 ppm ammonium solution to 50 mL with diluted HCL -R1.
Preparation of amino acid mixture stock
Weighed 30.560 mg of aspartic acid, 30.437 mg of threonine, 30.178 mg 
of serine, 30.269 mg of glutamic acid, 30.024 mg of proline, 30.462 mg 
of tryptophan, 30.173 mg of glycine, 30.698 mg of alanine, 
30.111 mg of valine, 30.171 mg of isoleucine, 30.121 mg of leucine, 
30.498 mg of tyrosine, 30.253 mg of ornithine HCL, 30.138 mg of 
histidine, 30.614 mg of arginine, 30.612 mg of taurine, 30.103 mg of 
phenylalanine, and 30.519 mg of lysine HCL, transferred into 50 mL 
volumetric flask, and diluted to the mark with diluted HCL R1.
Note: Stock solution for Amino acids was not prepared with water as 
the majority of the amino acids are sparingly soluble in water.
Preparation of amino acid mixture spiked with ammonium 
(Solution A: water)
Diluted 1 mL of amino acid stock mixture and 2 mL of ammonium ref (c) 
(diluted in water) into 200 mL with water.
Preparation of amino acid mixture spiked with ammonium 
(Solution A: Diluted HCL R1)
Diluted 1 mL of amino acid stock mixture and 2 mL of ammonium ref (c) 
(diluted in diluted HCL-R1) into 200 mL with diluted HCL-R1.
Concentration of amino acid mixture: 0.003 mg/mL and concentration 
of ammonium: 0.00012 mg/mL.
Preparation of individual amino acid for specificity
Individually prepared Threonine, Serine, Proline, Tryptophan, Alanine, 
Valine, Isoleucine, Leucine, Tyrosine and Phenylalanine using Dil 
HCl R1 as diluent. Individually prepared Aspartic acid, Glutamic 
acid , Ornithine HCl, Histidine, Arginine, Taurine, Glycine and Lysine 
HCl using water as diluent. All the amino acids were prepared with 
approximate concentration as 0.0012 mg/mL and ammonium in water 
with concentration as 0.000119828 mg/mL.
RESULTS
Relative retention time (RRT) was calculated with respect to isoleucine 
for amino acids injected individually as part of specificity study. No blank 
interference was observed at the retention time of any of the amino acids 
and ammonium. The chromatograms for blank, ammonium, and amino 
acid mixture chromatogram with blank overlay are shown in Figs. 1-3.
The specificity results shown the individual RRT as mentioned below:
Taurine eluted at 3.793 min with 0.07 RRT, aspartic acid eluted 
at 8.342 min with 0.16 RRT, threonine eluted at 9.452 min with 
0.18 RRT, serine eluted at 10.037 min with 0.19 RRT, glutamic acid 
eluted at 13.906 min with 0.27 RRT, proline eluted at 15.461 min 
with 0.29 RRT, glycine eluted at 17.645 min with 0.34 RRT, alanine 
eluted at 20.060 min with 0.38 RRT, valine eluted at 28.79 min with 
0.55 RRT, isoleucine eluted at 52.442 min with 1.00 RRT, leucine 
eluted at 58.050 min with 1.11 RRT, tyrosine eluted at 68.507 min 
with 1.31 RRT, phenylalanine eluted at 71.371 min with 1.36 RRT, 
ammonium eluted at 82.095 min with 1.57 RRT, tryptophan eluted 
at 97.663 min with 1.86 RRT, ornithine HCL eluted at 106.397 min 
with 2.03 RRT, lysine eluted at 109.354 min with 2.09 RRT, histidine 
eluted at 111.384 min with 2.12 RRT, and arginine eluted at 
126.571 min with 2.41 RRT. All the RRTs have been calculated with 
respect to isoleucine RT.
CONCLUSION
In this present work, it has been concluded that all the amino acids 
were eluted separately with no blank interference with the specificity 
study performed as part of the method development. The method has 
been successfully developed for the inclusion of amino acids such as 
taurine and ornithine HCL. The HPLC method shall be validated as per 
the ICHQ2R1 guidelines for its intended purpose. Once the method 
being validated, the validated method shall be used for routine analysis 
for the determination of NPS in amino acids.
Table 3: Pinnacle PCX column temperature gradient







Table 2: Pinnacle PCX post-column derivatization method
Run time (min) 134
Equilibration time (min) 1
Column temperature (°C) 145
Column type Sodium
Reactor temperature (°C) 130
Reactor volume (mL) 0.3
Pump 1 rate (mL/min) 0.3
Reagent 1 T200
Table 1: Gradient table
Time (min) Flow (mL/min) % A % B % C
0.0 0.4 100.0 0.0 0.0
30.0 0.4 100.0 0.0 0.0
60.0 0.4 85.0 15.0 0.0
85.0 0.4 10.0 90.0 0.0
85.5 0.4 10.0 90.0 0.0
120.0 0.4 0.0 0.0 100.0
130.0 0.4 0.0 0.0 100.0
132.0 0.4 100.0 0.0 0.0
135.0 0.4 100.0 0.0 0.0
53
Asian J Pharm Clin Res, Vol 11, Special issue 4, 2018, 51-53
Rajagopalachari and Shanmugasundaram
REFERENCES
1. European Pharmacopoeia. Amino acid Analysis. 9th ed., Vol. 1. 
New York: European Pharmacopoeia; 2017. p. 93.
2. European Pharmacopoeia. Glycine. 9th ed., Vol. 2. New York: European 
Pharmacopoeia; 2017. p. 2608.
3. European Pharmacopoeia. Alanine. 9th ed., Vol. 2. New York: European 
Pharmacopoeia; 2017. p. 1656.
4. European Pharmacopoeia. Arginine. 9th ed., Vol. 2. New York: European 
Pharmacopoeia; 2017. p. 1753.
5. European Pharmacopoeia. Histidine. 9th ed., Vol. 2. New York: 
European Pharmacopoeia; 2017. p. 2654.
6. European Pharmacopoeia. Isoleucine. 9th ed., Vol. 2. New York: 
European Pharmacopoeia; 2017. p. 2814.
7. European Pharmacopoeia. Leucine. 9th ed., Vol. 3. New York: European 
Pharmacopoeia; 2017. p. 2881.
8. European Pharmacopoeia. Lysine Hydrochloride., 9th ed., Vol. 3. 
New York: European Pharmacopoeia; 2017. p. 2935.
9. European Pharmacopoeia. Phenylalanine. 9th ed., Vol. 3. New York: 
European Pharmacopoeia; 2017. p. 3318.
10. European Pharmacopoeia. Proline. 9th ed., Vol. 3. New York: European 
Pharmacopoeia; 2017. p. 3424.
11. European Pharmacopoeia. Serine. 9th ed., Vol. 3. New York: European 
Pharmacopoeia; 2017. p. 3539.
12. European Pharmacopoeia. Threonine. 9th ed., Vol. 3. New York: 
European Pharmacopoeia; 2017. p. 3771.
13. European Pharmacopoeia. Tryptophan. 9th ed., Vol. 3. New York: 
European Pharmacopoeia; 2017. p. 3858.
14. European Pharmacopoeia. Tyrosine. 9th ed., Vol. 3. New York: European 
Pharmacopoeia; 2017. p. 3870.
15. European Pharmacopoeia. Valine. 9th ed., Vol. 3. New York: European 
Pharmacopoeia; 2017. p. 3890.
16. European Pharmacopoeia. Glutamic Acid. 9th ed., Vol. 2. New York: 
European Pharmacopoeia; 2017. p. 2593.
17. European Pharmacopoeia. Aspartic Acid. 9th ed., Vol. 2. New York: 
European Pharmacopoeia; 2017. p. 1764.
18. Nakano Y, Nohta H, Yoshida H, Todoroki K, Saita T, Fujito H, et al. 
Liquid chromatographic determination of ethambutol in serum samples 
based on intramolecular excimer-forming fluorescence derivatization. 
Anal Sci 2004;20:489-93.
19. Al-Ghannam S, Belal F. Spectrophotometric determination of three 
anti-ulcer drugs through charge-transfer complexation. J AOAC Int 
2002;85:1003-8.
20. Marchei E, Pellegrini M, Pacifici R, Palmi I, Pichini S. Development 
and validation of a high-performance liquid chromatography-mass 
spectrometry assay for methylxanthines and taurine in dietary 
supplements. J Pharm Biomed Anal 2005;37:499-507.
21. Available from: https://www.sgs.com/en/news/2016/06/amino-acid-
analysis.
22. Available from: https://www.pickeringlabs.com/wp-content/uploads/2015/03/
MA391_010415_Web.pdf.
Fig. 1: Typical chromatogram for water
Fig. 2: Typical chromatogram for ammonium
Fig. 3: Typical chromatogram for amino acid mixture and blank 
overlay
